The acylation-stimulating protein pathway and regulation of postprandial metabolism
- PMID: 9264120
- DOI: 10.1079/pns19970070
The acylation-stimulating protein pathway and regulation of postprandial metabolism
Abstract
Much has recently been learned about the processes involved in postprandial triacylglycerol clearance. As discussed previously, important differences in the metabolism of chylomicrons and VLDL have become apparent. The ASP pathway has also been recognized and appears to play a critical role in chylomicron metabolism. The ASP pathway is activated in order to trap the fatty acids released from chylomicrons by the action of LPL and there is now unequivocal in vivo evidence in human subjects that ASP is generated by adipocytes in the postprandial period. These findings match the in vitro data showing that chylomicrons, but not the other plasma lipoproteins or fatty acids, activate the generation of ASP by cultured human adipocytes. An inverse relationship appears to exist between the proportion of fatty acids taken up by adipocytes and that released into the general circulation. Too great a release into the general circulation because of diminished trapping of fatty acids released from chylomicrons appears to be critical in the pathogenesis of the dyslipoproteinaemias associated with hyperapo B or FCHL and omental obesity. Evidence has been presented that dysfunction of the ASP pathway may be one of the causes of this disorder. Put differently, the ASP pathway is essential for the normal clearance and disposition of dietary fatty acids. Binding of chylomicrons to capillary endothelium followed by lipolysis by LPL results in the sudden liberation of fatty acids, and in the marked generation of ASP by adipocytes. The ASP that is generated is essential if LPL is to continue to form fatty acids at a normal rate. It is essential also if the fatty acids which are formed are to enter the adipocyte rather than exit into the general circulation. The transport vehicle, the chylomicron, therefore stimulates the formation of the peptide, ASP, which is responsible for its successful metabolism. Thus, the ASP pathway provides the metabolic coordination between the chylomicron and the adipocyte, which we describe as microenvironmental metabolic regulation and which we believe is essential for the normal clearance of dietary triacylglycerol from plasma.
Similar articles
-
Acute in vitro production of acylation stimulating protein in differentiated human adipocytes.J Lipid Res. 1997 Jan;38(1):1-11. J Lipid Res. 1997. PMID: 9034195
-
Of mice and men (and women) and the acylation-stimulating protein pathway.Curr Opin Lipidol. 2000 Jun;11(3):291-6. doi: 10.1097/00041433-200006000-00010. Curr Opin Lipidol. 2000. PMID: 10882345 Review.
-
Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes.J Biol Chem. 1998 Aug 14;273(33):20903-9. doi: 10.1074/jbc.273.33.20903. J Biol Chem. 1998. PMID: 9694837
-
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes.J Lipid Res. 2004 Apr;45(4):657-66. doi: 10.1194/jlr.M300299-JLR200. Epub 2004 Jan 1. J Lipid Res. 2004. PMID: 14703506
-
Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.Semin Cell Dev Biol. 1999 Feb;10(1):31-41. doi: 10.1006/scdb.1998.0272. Semin Cell Dev Biol. 1999. PMID: 10355026 Review.
Cited by
-
Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.BMC Med Genomics. 2010 Jan 27;3:3. doi: 10.1186/1755-8794-3-3. BMC Med Genomics. 2010. PMID: 20105310 Free PMC article.
-
Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men.Am J Clin Nutr. 2016 Aug;104(2):324-33. doi: 10.3945/ajcn.116.133561. Epub 2016 Jul 6. Am J Clin Nutr. 2016. PMID: 27385608 Free PMC article. Clinical Trial.
-
Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature.Front Endocrinol (Lausanne). 2023 Aug 1;14:1218880. doi: 10.3389/fendo.2023.1218880. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600709 Free PMC article. Review.
-
CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism.Am J Pathol. 2011 Oct;179(4):1601-7. doi: 10.1016/j.ajpath.2011.06.015. Epub 2011 Aug 2. Am J Pathol. 2011. PMID: 21816131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials